Elsevier

Clinical Lymphoma

Volume 5, Issue 1, June 2004, Pages 29-36
Clinical Lymphoma

Comprehensive Review
Paraneoplastic Manifestations of Lymphoma

https://doi.org/10.3816/CLM.2004.n.007Get rights and content

Abstract

Paraneoplastic syndromes are manifestations of malignancies that have produced effects that are distant from the primary tumor or metastases. Paraneoplastic syndromes are not caused by local effects of compression or infiltration into tissues, but are generally due to ectopic hormone production, autoimmune phenomena, or overproduction of cytokines. Paraneoplasia may be the presenting symptom of underlying malignancy and can affect almost any organ system, such as the neurologic syndromes associated with small-cell lung cancer or hypercalcemia associated with squamous cell carcinomas. Lymphoproliferative disorders are also associated with many paraneoplastic disorders; however, to date, most published information has been in the form of case reports and series of small numbers of patients. In this review, the most common paraneoplastic syndromes associated with non-Hodgkin's lymphoma and Hodgkin's disease will be discussed.

References (131)

  • DH Lachance et al.

    Paraneoplastic brachial plexopathy in a patient with Hodgkin's disease

    Mayo Clin Proc

    (1991)
  • V Plante-Bordeneuve et al.

    Subacute sensory neuropathy associated with Hodgkin's disease

    J Neurol Sci

    (1994)
  • JP Osmanski et al.

    Necrotizing tracheobronchitis with progressive airflow obstruction associated with paraneoplastic pemphigus

    Chest

    (1997)
  • M Takahashi et al.

    Paraneoplastic pemphigus associated with bronchiolitis obliterans

    Chest

    (2000)
  • J Gille et al.

    Sweet's syndrome as initial presentation of diffuse large B-cell lymphoma

    J Am Acad Dermatol

    (2002)
  • E Rizos et al.

    Acquired icthyosis: a paraneoplastic skin manifestation of Hodgkin's disease

    Lancet Oncol

    (2002)
  • K Gronbaek et al.

    Autoimmune phenomena in non- Hodgkin's lymphoma

    Leuk Lymphoma

    (1995)
  • L Varoczy et al.

    Malignant lymphoma-associated autoimmune diseases—a descriptive epidemiological study

    Rheumatol Int

    (2002)
  • L Blornadal et al.

    Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus

    Scand J Rheumatol

    (2002)
  • J Cibere et al.

    Systemic lupus erythematosus and the risk of malignancy

    Lupus

    (2001)
  • F Matsuzuka et al.

    Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases

    Thyroid

    (1993)
  • ZH Abdul-Rahman et al.

    T-cell lymphoma in Hashimoto's thyroiditis

    Histopathology

    (1996)
  • DM Kraemer et al.

    Female patient with a history of Hashimoto's thyroiditis, diagnosed with MALT lymphoma of both breasts

    Onkologie

    (2003)
  • A Timuragaoglu et al.

    The significance of autoantibodies in non-Hodgkin's lymphoma

    Leuk Lymphoma

    (2000)
  • LF Diehl et al.

    Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia

    Semin Oncol

    (1998)
  • N Xiros et al.

    Idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in Hodgkin's disease

    Eur J Haematol

    (1988)
  • HM Taha et al.

    Fludarabine-related hemolytic anemia in chronic lymphocytic anemia and lymphoproliferative diseases

    Am J Hematol

    (1998)
  • RA Rudders et al.

    Hodgkin's disease presenting as “idiopathic” thrombocytopenic purpura

    Cancer

    (1972)
  • K Fink et al.

    Idiopathic thrombocytopenic purpura in lymphoma

    Cancer

    (1976)
  • L Shvidel et al.

    Successful treatment with rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low grade non-Hodgkin's lymphoma

    Am J Hematol

    (2001)
  • M Hensel et al.

    Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab

    Am J Hematol

    (2003)
  • Y Cohen et al.

    Monotherapy with rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma

    Leuk Lymphoma

    (2001)
  • M Hunault-Berger et al.

    Acquired von Willebrand disease and lymphoproliferative syndromes [in French]

    Presse Med

    (2001)
  • KP Rao et al.

    Acquired von Willebrand's syndrome associated with an extranodal pulmonary lymphoma

    Arch Pathol Lab Med

    (1988)
  • W Gesierich et al.

    Spontaneous bleeding in a patient with malignant lymphoma: a case of acquired hemophilia

    Onkologie

    (2000)
  • CW Tiplady et al.

    Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine

    Clin Lab Haematol

    (2000)
  • U Malik et al.

    Acquired Glanzmann's thrombasthenia associated with Hodgkin's lymphoma: a case report and review of the literature

    Cancer

    (1998)
  • I Genvresse et al.

    Arterial thrombosis associated with anticardiolipin and anti-beta 2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma: a report of two cases

    Eur J Haematol

    (2000)
  • E Di Biagio et al.

    Eosinophilia in Hodgkin's disease: a role for interleukin 5

    Int Arch Allergy Immunol

    (1996)
  • A Gallamini et al.

    Intestinal T-cell lymphoma with massive tissue and blood eosinophilia mediated by IL-5

    Leuk Lymphoma

    (1995)
  • IA Voutsadakis

    Fludarabine-induced eosinophilia: case report

    Ann Hematol

    (2002)
  • A Trojan et al.

    Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma

    Ann Hematol

    (2002)
  • T Robak et al.

    2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases

    Eur J Haematol

    (1997)
  • BG Gordon et al.

    Autoimmune neutropenia and Hodgkin's disease: successful treatment with intravenous gammaglobulin

    Am J Pediatr Hematol Oncol

    (1991)
  • A Schoengen et al.

    Immunoglobulin therapy for autoimmune neutropenia in Hodgkin's disease

    Acta Haematol

    (1995)
  • J Dwilewicz-Trojaczek et al.

    Thrombocytosis in patients with non- Hodgkin's lymphas and Hodgkin's disease [in Polish]

    Pol Arch Med Wewn

    (1997)
  • ML Randi et al.

    Incidence of thrombocytosis in lymphomas

    Leuk Lymphoma

    (1992)
  • JW Lynch et al.

    Pure red cell aplasia associated with angioimmunoblastic lymphadenopathy with dysproteinemia

    Am J Hematol

    (1994)
  • TJ Reid et al.

    Pure red cell aplasia after chemotherapy for Hodgkin's lymphoma: in vitro evidence for T cell mediated suppression of erythropoiesis and response to sequential cyclosporine and erythropoietin

    Am J Hematol

    (1994)
  • S Badve et al.

    Non-Hodgkin malignant lymphoma with tissue neutrophilia: a report of 3 cases

    Arch Pathol Lab Med

    (2000)
  • Cited by (40)

    • Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment

      2023, Best Practice and Research: Clinical Haematology
    • A Diverse Spectrum of Immune Complex– and Complement-Mediated Kidney Diseases Is Associated With Mantle Cell Lymphoma

      2022, Kidney International Reports
      Citation Excerpt :

      When considering a GN which does not fit the apparent clinical scenario, occult infection or neoplasia including lymphoproliferative disease are important considerations. A great variety of paraneoplastic autoimmune and rheumatologic features are well-documented in patients with lymphoma including MCL as well as solid-organ malignancies.33–36 Paraneoplastic kidney diseases associated with lymphoproliferative disorders but without direct Ig deposition are also well-recognized, and include C3GN,1,37–40 minimal change disease,41 thrombotic microangiopathy,1,42 and pauci-immune vasculitis.43

    • Pulmonary MALT lymphoma and paraneoplastic syndromes

      2016, Revue des Maladies Respiratoires
    • Gastric diffuse large B cell lymphoma presenting as paraneoplastic cerebellar degeneration: Case report and review of literature

      2013, Journal of the Egyptian National Cancer Institute
      Citation Excerpt :

      Paraneoplastic cerebellar degeneration (PCD) and other forms of paraneoplastic neurological disorders (PNDs) have been described in association with many solid tumors (like small-cell lung cancer and adenocarcinoma of the breast and ovary), Hodgkin’s lymphoma (HL) and very rarely with non-Hodgkin’s lymphoma (NHL) [1].

    • Paraneoplastic Glomerulopathy

      2013, Renal Disease in Cancer Patients
    View all citing articles on Scopus

    Electronic forwarding or copying is a violation of US and International Copyright Laws.

    Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Cancer Information Group, ISSN #1526-9655, provided the appropriate fee is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA 978-750-8400.

    View full text